Paper. Heles M, Pasvolsky L, Sathishkumar H et al.. Science, 3 Sep 2026.
Tags: Psilocybin, Pain, Cancer.
Two doses of psilocybin before platinum or taxane chemotherapy stopped peripheral neuropathy from developing, across repeated chemo cycles, without weakening the chemotherapy against tumors. The authors trace the effect to nerve cells keeping their mitochondria moving along the axon.
How much weight it carries: Animal study. A human trial testing psilocybin to prevent chemo-induced neuropathy is registered at MD Anderson. (Mice, Preclinical, Peer reviewed)
Psilocybin prevented chemotherapy nerve damage in mice without blunting the chemo.
Two doses before platinum- or taxane-based chemotherapy preserved tactile sensitivity and nerve fibre endings by keeping mitochondria moving along axons, and an accompanying Science commentary frames this as prophylaxis rather than treatment. A separate Cancer Discovery paper reports a non-hallucinogenic LSD analogue boosting the immune response to colorectal cancer; both results are preclinical.